Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

In March, short sellers collectively increased their negative bets on the broader healthcare industry, as indicated by a rise ...

From fluoride, vaccines and beef tallow, here's how he might "go wild" on biotech stocks. CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine official at the U.S.

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, last year, the company brought in $3.2 billion in revenue, compared to more ...

"There will not be any research funded by NIH on mRNA vaccines," the scientist in New York similarly told the outlet. "MAGA people are convinced that these vaccines have killed and maimed tens of ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft ...